Thymosin β4 promotes the recovery of peripheral neuropathy in type II diabetic mice

Neurobiology of Disease

Volumn 48, Issue 3, 2012, Pages 546-555

  Wang, Lei ^a   Chopp, Michael ^a,b   Szalad, Alexandra ^a   Liu, Zhongwu ^a   Lu, Mei ^a   Zhang, Li ^a   Zhang, Jing ^a   Zhang, Rui Lan ^a   Morris, Dan ^a   Zhang, Zheng Gang ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

Diabetes; Mice; Peripheral neuropathy; T 4

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; GLUCOSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THYMOSIN BETA4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CAPILLARY DENSITY; CONTROLLED STUDY; DIABETIC PERIPHERAL NEUROPATHY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LASER-DOPPLER FLOWMETRY; MICE; NEUROPROTECTIVE AGENTS; REAL-TIME POLYMERASE CHAIN REACTION; REGIONAL BLOOD FLOW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; SCIATIC NERVE; SIGNAL TRANSDUCTION; THYMOSIN;

EID: 84865570032     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.08.002     Document Type: Article

References (58)

1. Bock-Marquette I., Saxena A., White M.D., Dimaio J.M., Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004, 432:466-472.
2. Cameron N.E., Cotter M.A. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 1999, 45:137-146.
3. Cameron N.E., Eaton S.E., Cotter M.A., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001, 44:1973-1988.
4. Cameron N.E., Gibson T.M., Nangle M.R., Cotter M.A. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann. N. Y. Acad. Sci. 2005, 1043:784-792.
5. Campana W.M. Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav. Immun. 2007, 21:522-527.
6. Chen J.X., Stinnett A. Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice. Diabetes 2008, 57:3335-3343.
7. Chen J.X., Stinnett A. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1606-1613.
8. ClinicalTrials.gov http://clinicaltrials.gov/ct2/show/NCT01311518.
9. Crockford D. Development of thymosin beta4 for treatment of patients with ischemic heart disease. Ann. N. Y. Acad. Sci. 2007, 1112:385-395.
10. Crockford D., Turjman N., Allan C., Angel J. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Ann. N. Y. Acad. Sci. 2010, 1194:179-189.
11. Ebenezer G.J., O'Donnell R., Hauer P., Cimino N.P., McArthur J.C., Polydefkis M. Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomy. Brain 2011, 134:1853-1863.
12. Freeman K.W., Bowman B.R., Zetter B.R. Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB J. 2011, 25:907-915.
13. Frostick S.P., Yin Q., Kemp G.J. Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 1998, 18:397-405.
14. Goldstein A.L., Slater F.D., White A. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc. Natl. Acad. Sci. U. S. A. 1996, 56:1010-1017.
15. Goukassian D., Diez-Juan A., Asahara T., Schratzberger P., Silver M., Murayama T., Isner J.M., Andres V. Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J. 2001, 15:1877-1885.
16. Grant D.S., Kinsella J.L., Kibbey M.C., LaFlamme S., Burbelo P.D., Goldstein A.L., Kleinman H.K. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J. Cell Sci. 1995, 108(Pt. 12):3685-3694.
17. Ii M., Nishimura H., Kusano K.F., Qin G., Yoon Y.S., Wecker A., Asahara T., Losordo D.W. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation 2005, 112:93-102.
18. Janssen P.A., Niemegeers C.J., Dony J.G. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Arzneimittelforschung 1963, 13:502-507.
19. Jeong J.O., Kim M.O., Kim H., Lee M.Y., Kim S.W., Ii M., Lee J.U., Lee J., Choi Y.J., Cho H.J., Lee N., Silver M., Wecker A., Kim D.W., Yoon Y.S. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy. Circulation 2009, 119:699-708.
20. Kim H.K., Kim Y.J., Kim J.T., Kwon C.H., Kim Y.K., Bae Y.C., Kim D.H., Jung J.S. Alterations in the proangiogenic functions of adipose tissue-derived stromal cells isolated from diabetic rats. Stem Cells Dev. 2008, 17:669-680.
21. Kusano K.F., Allendoerfer K.L., Munger W., Pola R., Bosch-Marce M., Kirchmair R., Yoon Y.S., Curry C., Silver M., Kearney M., Asahara T., Losordo D.W. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2102-2107.
22. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., Kwon Y.G. Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 1999, 264:743-750.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
24. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
25. Mora C.A., Baumann C.A., Paino J.E., Goldstein A.L., Badamchian M. Biodistribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice. Int. J. Immunopharmacol. 1997, 19:1-8.
26. Morris D.C., Chopp M., Zhang L., Lu M., Zhang Z.G. Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke. Neuroscience 2010, 169:674-682.
27. Pande M., Hur J., Hong Y., Backus C., Hayes J.M., Oh S.S., Kretzler M., Feldman E.L. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: a model of type 2 diabetes. Diabetes 2011, 60:1981-1989.
28. Perrone L., Peluso G., Melone M.A. RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes. J. Cell. Physiol. 2008, 217:60-71.
29. Philp D., Badamchian M., Scheremeta B., Nguyen M., Goldstein A.L., Kleinman H.K. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003, 11:19-24.
30. Qiu F.Y., Song X.X., Zheng H., Zhao Y.B., Fu G.S. Thymosin beta4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. J. Cardiovasc. Pharmacol. 2009, 53:209-214.
31. Rasul S., Reiter M.H., Ilhan A., Lampichler K., Wagner L., Kautzky-Willer A. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study. Cardiovasc. Diabetol. 2011, 10:55.
32. Ruff D., Crockford D., Girardi G., Zhang Y. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann. N. Y. Acad. Sci. 2010, 1194:223-229.
33. Said G. Diabetic neuropathy-a review. Nat. Clin. Pract. Neurol. 2007, 3:331-340.
34. Schratzberger P., Schratzberger G., Silver M., Curry C., Kearney M., Magner M., Alroy J., Adelman L.S., Weinberg D.H., Ropper A.H., Isner J.M. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat. Med. 2000, 6:405-413.
35. Schratzberger P., Walter D.H., Rittig K., Bahlmann F.H., Pola R., Curry C., Silver M., Krainin J.G., Weinberg D.H., Ropper A.H., Isner J.M. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J. Clin. Invest. 2001, 107:1083-1092.
36. Smart N., Risebro C.A., Melville A.A., Moses K., Schwartz R.J., Chien K.R., Riley P.R. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445:177-182.
37. Smart N., Risebro C.A., Melville A.A., Moses K., Schwartz R.J., Chien K.R., Riley P.R. Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann. N. Y. Acad. Sci. 2007, 1112:171-188.
38. Sobue G. The role of Schwann cells in peripheral nerve degeneration and regeneration-NGF-NGF receptor system. Rinsho Shinkeigaku 1990, 30:1358-1360.
39. South S.M., Smith M.T. Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats. J. Pharmacol. Exp. Ther. 1998, 286:1326-1332.
40. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
41. Teichert-Kuliszewska K., Maisonpierre P.C., Jones N., Campbell A.I., Master Z., Bendeck M.P., Alitalo K., Dumont D.J., Yancopoulos G.D., Stewart D.J. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 2001, 49:659-670.
42. Tesfaye S., Harris N., Jakubowski J.J., Mody C., Wilson R.M., Rennie I.G., Ward J.D. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993, 36:1266-1274.
43. Tesfaye S., Boulton A.J., Dyck P.J., Freeman R., Horowitz M., Kempler P., Lauria G., Malik R.A., Spallone V., Vinik A., Bernardi L., Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010, 33:2285-2293.
44. Thebaud B., Ladha F., Michelakis E.D., Sawicka M., Thurston G., Eaton F., Hashimoto K., Harry G., Haromy A., Korbutt G., Archer S.L. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005, 112:2477-2486.
45. Tuo Q.H., Zeng H., Stinnett A., Yu H., Aschner J.L., Liao D.F., Chen J.X. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2547-H2557.
46. Vanderah T.W., Suenaga N.M., Ossipov M.H., Malan T.P., Lai J., Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J. Neurosci. 2001, 21:279-286.
47. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004, 35:1732-1737.
48. Wang L., Gang Zhang Z., Lan Zhang R., Chopp M. Activation of the PI3-K/Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J. Cereb. Blood Flow Metab. 2005, 25:1150-1158.
49. Wang L., Chopp M., Szalad A., Liu Z., Bolz M., Alvarez F.M., Lu M., Zhang L., Cui Y., Zhang R.L., Zhang Z.G. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice. Neuroscience 2011, 193:399-410.
50. Wang Y., Li Z., Xu P., Huang L., Tong J., Huang H., Meng A. Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis. J. Biol. Chem. 2011, 286:41095-41104.
51. Wu Q.D., Wang J.H., Fennessy F., Redmond H.P., Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am. J. Physiol. 1999, 277:C1229-C1238.
52. Xiong Y., Mahmood A., Meng Y., Zhang Y., Zhang Z.G., Morris D.C., Chopp M. Treatment of traumatic brain injury with thymosin beta in rats. J. Neurosurg. 2011, 114:102-115.
53. Xiong Y., Zhang Y., Mahmood A., Meng Y., Zhang Z.G., Morris D.C., Chopp M. Neuroprotective and neurorestorative effects of thymosin beta4 treatment initiated 6 hours after traumatic brain injury in rats. J. Neurosurg. 2012, 116:1081-1092.
54. Zhang Z., Zhang R.L., Jiang Q., Raman S.B., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1997, 17:123-135.
55. Zhang Z., Davies K., Prostak J., Fenstermacher J., Chopp M. Quantitation of microvascular plasma perfusion and neuronal microtubule-associated protein in ischemic mouse brain by laser-scanning confocal microscopy. J. Cereb. Blood Flow Metab. 1999, 19:68-78.
56. Zhang R., Wang L., Zhang L., Chen J., Zhu Z., Zhang Z., Chopp M. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ. Res. 2003, 92:308-313.
57. Zhang R., Zhang Z., Wang L., Wang Y., Gousev A., Zhang L., Ho K.L., Morshead C., Chopp M. Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats. J. Cereb. Blood Flow Metab. 2004, 24:441-448.
58. Zhang J., Zhang Z.G., Morris D., Li Y., Roberts C., Elias S.B., Chopp M. Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis. Neuroscience 2009, 164:1887-1893.